Drug Pipeline

Nicotinamide riboside Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT04332341
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell…		 date change Primary completion pushed: 2026-07 -> 2026-09
2026-05-27 NCT07579429
Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)		 Recruitment opened
Active Studies by Phase
Phase 4
1
Phase 2
2
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05483465 The Effect of NAD Supplementation on Brain Vascular Health in Aging Aging Recruiting
Phase 2
NCT07579429 Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial) Clonal Cytopenia of Undetermined Significance Recruiting
NCT04040959 Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated… Vascular Diseases Active, Not Recruiting
Early Phase 1
NCT04332341 Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell… Allogeneic Hematopoietic Cell Transplantation Recruiting
NCT04430517 Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive… Mild Cognitive Impairment Active, Not Recruiting
Sponsors Running Nicotinamide riboside Trials
University of Colorado, Denver (2) Case Comprehensive Cancer Center (1) Mclean Hospital (1) University of Oklahoma (1)
Disease Areas
Chronic Kidney Disease (1) Alzheimer's Disease (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Nicotinamide riboside trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free